RT Journal Article SR Electronic T1 Polypharmacy: A Case Report and New Protocol for Management JF The Journal of the American Board of Family Practice JO J Am Board Fam Med FD American Board of Family Medicine SP 140 OP 144 DO 10.3122/15572625-11-2-140 VO 11 IS 2 A1 Lee, R. David YR 1998 UL http://www.jabfm.org/content/11/2/140.abstract AB Background: Polypharmacy is an important issue in primary care, yet few data are available concerning its prevalence, complications, and management in clinical medicine. The following case illustrates the clinical perils of polypharmacy and serves as a point for critical discussion. Methods: MEDLINE was searched, using the key word “polypharmacy” from 1994 to the present. A case report of polypharmacy is described, and a novel protocol for the management of polypharmacy is proposed. Results: Polypharmacy can lead to unnecessary expense, wasted time, and embarrassment on the part of the patient and confusion and mismanagement on the part of the physician. The literature reveals controversy surrounding the definition of polypharmacy and reflects the considerable morbidity and expense associated with polypharmacy. Finally, the SAIL protocol shows that physicians need to keep in mind simplicity, adverse effects, indications, and a precise list of all medications to manage appropriately a patient's drug regimen. Conclusions: Polypharmacy is associated with morbidity and iatrogenic complications. The SAIL protocol can be a useful tool in the management of this entity. More research needs to be done on the prevalence, complications, and management of polypharmacy.